Solid Biosciences Inc expected to post a loss of 67 cents a share - Earnings Preview

Solid Biosciences

04/11/2024 21:17

* Solid Biosciences Inc  SLDB.OQ   SLDB.O  is expected
to show no
change in quarterly revenue when it reports  results on November
6 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Solid Biosciences Inc is
for a
loss of 67 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is 16.50​, above​ its last closing price of $5.75. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.66       -0.66                        8.1
 Jan. 1 0001   -0.65       -0.64                        -0.1
 Dec. 31 2023  -1.04       -0.99      -1.00     Missed  -1.2​
 Sep. 30 2023  -1.19       -1.19      -1.05     Beat    11.6
 ​​Jun.        -1.55                  -1.25             18.6
 30 2023                                                
 Mar. 31 2023  -2.21                  -1.50             26.9​
 Dec. 31 2022              -1.65      -2.82     Missed  -70.7
 Sep. 30 2022  -2.57       -2.67      -2.71     Missed  -1.5
 This summary was machine generated November 4 at 21:16 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)